ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Alpha Cognition Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.50+0.31 (+3.79%)
Close on Oct 19, 2026
- Market cap
- $185.08M
- P/E (TTM)
- –
- Dividend yield
- –
Alpha Cognition statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Market Cap | $185.11M | $164.85M |
| Enterprise Value | $143.73M | $87.06M |
| PS Ratio | 12.13 | 3.60 |
| PB Ratio | 3.50 | 2.03 |
| P/TBV Ratio | 3.96 | 2.31 |
Enterprise value
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| EV / Sales | 9.42 | 2.43 |
Income (trailing twelve months)
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Revenue | $15.26M | $57.94M |
| Gross Profit | $14.15M | $90.47M |
| Operating Income | -$29.09M | -$21.44M |
| Net Income | -$23.44M | -$22.46M |
| EBITDA | -$28.92M | -$16.91M |
Margins
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Gross Margin | 92.7% | 52.3% |
| Operating Margin | -190.6% | -44.5% |
| Profit Margin | -153.6% | -39.2% |
| EBITDA Margin | -189.5% | -31.3% |
| FCF Margin | -204.3% | -8.85% |
Returns
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Return on Equity (ROE) | -58.8% | -53.1% |
| Return on Assets (ROA) | -42.8% | -41.0% |
| Return on Capital Employed (ROCE) | -50.1% | -37.8% |
Balance sheet
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $41.38M | $62.42M |
| Net Cash (Debt) | $41.38M | $15.68M |
| Net Cash Per Share | $1.90 | $0.66 |
| Equity (Book Value) | $52.96M | $48.79M |
| Book Value Per Share | $2.43 | $1.36 |
| Tangible Book Value | $46.74M | $23.06M |
| Working Capital | $51.51M | $75.77M |
Financial position
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Current Ratio | 9.03 | 3.30 |
| Quick Ratio | 7.31 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Operating Cash Flow | -$30.85M | -$12.35M |
| Capital Expenditures | -$321.80K | -$1.06M |
| Free Cash Flow | -$31.18M | -$20.28M |
| FCF Per Share | -$1.43 | -$0.42 |
Efficiency
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Asset Turnover | 0.28 | 0.38 |
| Inventory Turnover | 0.31 | 2.67 |
| Revenue Per Employee | $211.95K | $398.96K |
| Profits Per Employee | -$325.59K | -$703.34K |
| Employee Count | 72 | 74 |
Dividends and yields
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Earnings Yield | -12.7% | -22.7% |
| FCF Yield | -16.8% | -9.07% |
Shares
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Shares Outstanding | 21,777,900 | 58,179,650 |
| Shares Change (YoY) | 67.3% | 11.1% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 20,631,200 | 49,173,100 |
| Shares Held by Insiders | 5.27% | 11.6% |
| Shares Held by Institutions | 48.7% | 59.4% |
Scores
| Measure | Alpha Cognition | Industry median |
|---|---|---|
| Altman Z-Score | 6.88 | -0.24 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Alpha Cognition's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.